Primify Medico India Private Limited
About Primify Medico India Private Limited
Data last updated:
Primify Medico India Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the manufacturing segment of the healthcare sector. It was incorporated on 23 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33100TN2019PTC131232.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vishnurambalasubramaniam and Mannan Kavitha Ranjani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 7/4 11th Cross Street 2nd Main Road Besant Nagar, Chennai, Tamil Nadu, India – 600090.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.86 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹13,361 (net margin 0.8%) and EBITDA of ₹18,056 (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 25% over five years.
Company details
Contact details
Primify Medico India Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressB – 7/4 11th Cross Street 2nd Main Road Besant Nagar, Chennai, Tamil Nadu, India – 600090
- IndustryHealthcare, Manufacturing, Medical Appliances And Instruments
To see the full contact details of Primify Medico India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Primify Medico India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Primify Medico India Private Limited, buy the company report.
Financials of Primify Medico India Private Limited
FY 2025 filings availablePrimify Medico India Private Limited reported revenue of ₹16.86 Lakh (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 4% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18,056 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13,361 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Primify Medico India Private Limited, buy the company report.
Board of directors of Primify Medico India Private Limited
Primify Medico India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishnurambalasubramaniam | Director | 23 Aug 2019 | 7 Years 2 Months | Current |
| Mannan Kavitha Ranjani | Director | 23 Aug 2019 | 7 Years 2 Months | Current |
Peer comparison
Primify Medico India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| San Surfactants Private Limited | ₹16.91 Lakh (FY 2025) | -41.0% | Secunderabad, Telangana, India | |||
| Scot Chemicals and Minerals Private Limited | ₹16.9 Lakh (FY 2025) | -26.0% | Jaipur, Rajasthan, India | |||
| Mayur Ceramics Pvt Ltd | ₹16.88 Lakh (FY 2016) | -80.0% | Mayurbhanj, Odisha, India | |||
| Celestial Biolabs Limited | ₹16.87 Lakh (FY 2023) | 14.0% | Hyderabad, Telangana, India | |||
| Leribrain Pharmaceutical (OPC) Private Limited | ₹16.86 Lakh (FY 2025) | -15.0% | Lucknow, Uttar Pradesh, India | |||
| Primify Medico India Private Limitedthis company | ₹16.86 Lakh (FY 2025) | ₹13,361 | 0.8% | 4.0% | Chennai, Tamil Nadu, India | |
| Sonex Aroma Products Private Limited | ₹16.84 Lakh (FY 2016) | 103.0% | Udaipur, Rajasthan, India | |||
| Captain Plastic Private Limited | ₹16.84 Lakh (FY 2025) | 103.0% | Rajkot, Gujarat, India | |||
| Chemford Life Sciences Private Limited | ₹16.81 Lakh (FY 2024) | 26.0% | Kottakkal, Kerala, India | |||
| Laurel Perfumes (India) Private Limited | ₹16.81 Lakh (FY 2025) | 1147.0% | Chennai, Tamil Nadu, India | |||
| United Tex Chem Solutions Private Limited | ₹16.81 Lakh (FY 2025) | -74.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Primify Medico India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Primify Medico India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Primify Medico India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Primify Medico India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Primify Medico India Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Mannan Kavitha Ranjani was appointed as Director on 23 Aug 2019.
Frequently asked questions
Primify Medico India is an active private limited company based in Chennai, Tamil Nadu, India. The company works in manufacturing, within the healthcare industry. It was incorporated on 23 August 2019 (7+ years old) and is registered under CIN U33100TN2019PTC131232.
Primify Medico India has 2 current directors:
- Vishnurambalasubramaniam - Director
- Mannan Kavitha Ranjani - Director
The latest financial statements of Primify Medico India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Primify Medico India is U33100TN2019PTC131232. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Primify Medico India was incorporated on 23 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Primify Medico India by revenue are San Surfactants Private Limited, Scot Chemicals and Minerals Private Limited, Mayur Ceramics Pvt Ltd, Celestial Biolabs Limited, Leribrain Pharmaceutical (OPC) Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mannan Kavitha Ranjani was appointed as Director on 23 Aug 2019. Vishnurambalasubramaniam was appointed as Director on 23 Aug 2019.
The registered office of Primify Medico India is at B – 74 11th Cross Street 2nd Main Road Besant Nagar, Chennai, Tamil Nadu, India – 600090.
Primify Medico India operates in the healthcare industry, in the manufacturing segment.
Primify Medico India can be reached at its registered office: B – 74 11th Cross Street 2nd Main Road Besant Nagar, Chennai, Tamil Nadu, India – 600090.
Primify Medico India is registered under the jurisdiction of the Registrar of Companies (ROC), Chennai.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
